How are all the thousands of hospitals around the world and here in the US gearing up to deal with the potential arrival of a patient with Ebola? The importance of this issue and how it is resonating so strongly in the medical field hit home for me a bit more a few days ago […]
Ebola prevention hits home Read More »
All the recent high-profile papers that are having troubles are bumming me out, with the latest example being the “Betatrophin” Diabetes paper from Harvard last year. Yesterday it was called into major doubt by a new Cell paper from a group led by Jesper Gromada at Regeneron. The authors of the original 2013 Betatrophin paper–Doug Melton’s team at Harvard– indicated
The Betatrophin Blues after Harvard Diabetes pub Read More »
With more than 4,142 votes cast, the readers of this blog have chosen the top 12 finalists for the Stem Cell Person of the Year Award for 2014 from the 27 nominees. You can see the final vote tallies at left. The votes came from more than 50 countries with some interesting geographic patterns (I
Diverse Stem Cell Person of the Year 2014 Award Finalists Read More »
I invited Nobel Laureate Shinya Yamanaka to do an interview on the future of clinical translation of induced pluripotent stem cells (iPSC). He provides some intriguing new insights into the iPSC field and the broader stem cell arena. PK: The Takahashi Team’s active Clinical Study using iPSCs to make RPEs to treat Macular Degeneration has
Shinya Yamanaka Interview on Clinical Use of IPSC Read More »
In two days the voting will end to pick the top 12 finalists for Stem Cell Person of the Year 2014 Award. You can vote here. From the finalists I will have the tough decision of picking the winner. Check out who’s in the top 12 now and who the top few vote getters are. Will someone surge
Stem Cell Person of the Year Award: Only 2 Days Left To Vote Read More »
In a few days it will be the 5-year anniversary of my diagnosis with a very serious form of prostate cancer. So far since then I’ve been doing pretty well (knock on wood). I am still getting PSA tested and life still has a cancer thread through it for me. As much as having cancer is
Prostate cancer postcards Read More »
The STAP cell mess that began in January of this year has in some ways quieted down. In a broader sense, I believe that STAP is now and will be in the future viewed as a scandal that revealed some less than ideal aspects to the world of biomedical science and publishing. Where does this
STAP Cell Update: STAP-like paper, Real Origin of STAP cells Read More »
With one week left to vote to pick the top 12 finalists for the Stem Cell Person of the Year 2014 Award, we have more than 2,800 votes in so far. From the top 12 vote-getters, I will choose the winner. This is the third year of this award. I self-fund this award out of
Stem Cell Person of the Year Award 2014 Voting: Who Will Be Finalists? Read More »
The stem cell biotech Advanced Cell Technology (ACT) reported new, positive data in a paper in Lancet from their clinical trials using retinal pigmented epithelial cells (RPEs) made from human embryonic stem cells (hESC) for treatment of different forms of macular degeneration (MD). The paper was entitled “Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related
Advanced Cell Technology pub: Trial for Macular Degeneration Read More »
It’s hard to even imagine the world of investigative medicine without the wonderful resource of Clinicaltrials.gov, the global hub for clinical trial listings. I recently interviewed the Director of Clinicaltrials.gov, Dr. Deborah Zarin here, which is a fascinating read. As great as Clinicaltrials.gov is as a resource, unfortunately it faces a new, rapidly growing problem that is a serious
Clinicaltrials.gov Mission At Risk From Proliferating For-Profit Trials Read More »